HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hmed Ben-Nasr Selected Research

tetradifon

7/2020Pathophysiological impacts of exposure to an endocrine disruptor (tetradifon) on α-amylase and lipase activities associated metabolic disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hmed Ben-Nasr Research Topics

Disease

1COVID-19
01/2022
1Type 2 Diabetes Mellitus (MODY)
07/2020
1Hyperlipidemias (Hyperlipidemia)
07/2020
1Obesity
07/2020
1Liver Failure
12/2019
1Breast Neoplasms (Breast Cancer)
03/2014
1Neoplasms (Cancer)
03/2014

Drug/Important Bio-Agent (IBA)

1artemisinin (artemisinine)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1Peptide Hydrolases (Proteases)FDA Link
01/2022
1tetradifonIBA
07/2020
1Endocrine DisruptorsIBA
07/2020
1Mefenamic Acid (Pontal)FDA Link
12/2019
1alpha-TocopherolFDA Link
03/2014
1Vitamin EFDA LinkGeneric
03/2014